Shenzhen Kangtai Biological Products

Shenzhen Kangtai Biological Products Overview

Founded 1988
Status Public
Employees 1,336
Stock Symbol 300601
Stock Symbol
Share Price $19.82 (As of Monday Closing)

Shenzhen Kangtai Biological Products General Information


Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Delivery
Stock Exchange
Primary Office
  • Kefa Road 6, Science & Industry Park
  • Nanshan
  • Shenzhen
  • China
+86 0755 0000 0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Shenzhen Kangtai Biological Products Stock Performance

(As of Tuesday closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$19.82 $20.55 $6.43 - $21.48 $13.3B 672M 4.58M $0.11

Shenzhen Kangtai Biological Products Financials Summary

In Thousands,
TTM 31-Mar-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018 FY 2017 31-Dec-2017
EV 10,398,610 8,104,053 3,333,628 3,071,793
Revenue 255,394 281,279 304,885 171,824
EBITDA 79,262 108,821 85,466 44,079
Net Income 68,510 83,154 65,860 31,771
Total Assets 547,047 564,888 485,019 338,615
Total Debt 25,318 28,015 59,985 37,899
Public Fundamental Data provided by Morningstar, Inc. disclaimer